Results 161 to 170 of about 48,373 (242)

Nucleos(t)ide analogue therapy combined with pegylated interferon α-2b guided by the GOLDEN prediction model for functional cure of chronic hepatitis B: study protocol (GIFT project). [PDF]

BMJ Open
Chai S, Jiang J, Wang C, He Y, Jia X, Xi Q, Jing F, Chang L, Zhang W, Guo Y, Du F, Feng J, Chai Y, Cao Y, Li F, Zhang L, Chen S, Wang Y, Lin Y, Cao H, Zhang Y, Liang Y, Li F, Hao Y, Gao X, Li H, Zhang Y, Kang W.   +27 more
europepmc   +1 more source

[Exploration of antiviral regimens for patients with chronic hepatitis B virus infection in the indeterminate phase]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Zheng J, Li XW, Long L, Liu X, Yuan S, Wang SP, Cheng LC, Wang X, Long GY.   +8 more
europepmc   +1 more source

Drug resistance mutations of hepatitis B virus (HBV) influence the yield of the virions of the human hepatitis delta virus (HDV) and their infectivity. [PDF]

J Virol
Chazova O, Zaiets I, Gudima SO.
europepmc   +1 more source

Quantitative HBsAg as a biomarker for disease staging in untreated chronic hepatitis B patients: a cross-sectional study. [PDF]

Front Med (Lausanne)
Mrabet S, Handous I, Trabelsi O, Maatouk Y, Harbi R, Akkari I, Hannachi N, Ben Jazia E.   +7 more
europepmc   +1 more source

Single- and dual-target CAR-T cells targeting HBsAg and GPC3 to balance safety and antitumor efficacy in HBV-positive hepatocellular carcinoma. [PDF]

iScience
Chen Q, Chen Z, Xu D, Wang H, Hu A, Hu Z, Gao P, Li H, Li Y, Sun L, Gao K, Hou H, Di J, Chai K, Zhu B, Zhang Q, Wang G, Xu W, Han Z, Zheng J, Liu Y.   +20 more
europepmc   +1 more source

Low-level hepatitis B surface antigen by ECLIA stratifies early relapse risk in patients with interferon-based HBV functional cure. [PDF]

Front Immunol
Li X, Wu B, Xie H, Hu H, Liu T, You X, Bi Y, Gu Y.   +7 more
europepmc   +1 more source

Two Diagnostic Challenges in Hepatitis B Serology: Low HBsAg S/CO Values and Isolated Anti-HBc Positivity. [PDF]

Pathogens
Yılmaz Gürbüz Ş, Yağdı O, Başar E.   +2 more
europepmc   +1 more source

Hepatitis B in Isolated Anti-HBc Carriers: Predictors of Detectable HBV DNA and Implications for Risk-Stratified Screening. [PDF]

Viruses
Zeybek H.
europepmc   +1 more source

Traditional Chinese Medicine in Chronic Hepatitis B: Integrating Antiviral Effects and Immune Modulation in the Context of T Cell Exhaustion. [PDF]

Drug Des Devel Ther
Zhao X, Mei C, Cheng FE, Li S, Zheng S, Qi W, Ye Y.   +6 more
europepmc   +1 more source

Clinically Relevant Risk of Hepatitis B Virus Infection and Reactivation in People With HIV After Withdrawal of Anti-HBV-Active Antiretroviral Therapy in Japan. [PDF]

Open Forum Infect Dis
Adachi E, Okazaki A, Kanno Y, Koga M, Yotsuyanagi H.   +4 more
europepmc   +1 more source